Psyence Biomedical ltd (PBM) Annual Balance Sheets

Annual · GAAP · USD millions
Access PBM quarterly Balance Sheets →
The table below presents a historical view of Psyence Biomedical ltd's balance sheet, supporting analysis of financial position trends.
Annual Report, GAAP in USD millions
ITEM
(Mar 31 2025)
(Mar 31 2024) (Jan 31 2023) (Jan 31 2022) (Jan 31 2021)
Assets
Cash And Cash Equivalents6.14
Cash & Short-term Investments6.00
Other Current Assets0.00
Total Current Assets6.56
Equipment/Property/Plant Net0.01
Other Assets, Noncurrent0.00
Current Restricted Cash And Cash Equivalents0.03
Other Current Receivables0.04
Current Prepayments0.32
Mineral Property Interests-
Tangible Exploration And Evaluation Assets0.32
Trade And Other Current Payables0.76
Ifrs Convertible Debt Current7.66
Current Warrant Liability0.90
Total Assets7.32
Liabilities
Accounts Payable0.00
Other Liabilities, Current0.00
Deferred Liability and Revenue0.08
Total Current Liabilities0.08
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Total Liabilities0.59
Stockholders' Equity
Other Equity0.00
Common Stockholder's Equity6.72
Total Stockholder's Equity6.72
Liabilities & Stockholder's Equity7.32
4 historic quarters locked

Sign in to unlock the full Psyence Biomedical ltd balance sheet history.

About Psyence Biomedical Ltd Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-070607

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License